Harvard Apparatus Regenerative Technology, Inc.
Holliston, United States
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Harvard Apparatus Regenerative Technology, Inc was founded by Thomas McNaughton, Thomas Robinson, La Francesca Saverio, James McGorry, John Kennedy, John Canepa, Blaine McKee, Wei Zhang, Matthew Dallas, Peter Chakoutis, Jeffrey Young, Jing Chen, Hong Yu, James Shmerling, William Fodor, Ting Li, Shunfu Hu, Herman Sanchez, Junli He, David Green, Ronald Packard, Joseph Damasio and Mao Zhang, and is based in Holliston, United States.
Key facts
- Industry
- Biotechnology
- Legal form
- Incorporated in Delaware
- Listed
- OTC · HRGN
About
Surgical & Medical Instruments & Apparatus; formerly Biostage, Inc.; listed on OTC as HRGN; filing with the SEC since 2012
Founders
Chief Financial Officer
1500 Founder Rating
Director
1500 Founder Rating
EVP and Chief Medical Officer
1500 Founder Rating
President and CEO
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Vice President of Finance
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Chief Scientific Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
In context
We hold 2,331 other biotechnology companies. None has a closure on record yet. Of the 2,210 that report what they raised, the median is $3,512,633.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment